The Role of MicroRNAs in the Pathogenesis of Endometrial Cancer: a Systematic Review
Overview
Authors
Affiliations
Introduction: Epigenetics seem to play a primary role in the current research on the pathogenesis of different types of endometrial cancer. Data so far indicate that microRNAs regulate different pathways that could lead to carcinogenesis when not functioning properly. The aim of this review is to summarize current knowledge on microRNAs that have been associated with endometrial cancer development.
Material And Methods: From July 2014 to August 2014, we conducted a comprehensive research utilizing major online search engines (Pubmed, Crossref, Google Scholar). The main keywords used in our search were endometrial cancer/carcinoma; microRNA; epigenetics; novel biomarkers; pathogenesis.
Results: Overall, we identified 155 studies, although only 77 were eligible for this review. Different miRNAs were identified to contribute either promoting the carcinogenesis in the endometrium or inhibiting different steps of endometrial cancer development. Tumour growth, cell proliferation, apoptosis and invasion metastasis have been identified as the main processes where miRNAs seem to be implicated.
Conclusions: microRNAs are effective regulators of gene expression that has a significant role in the pathogenesis of endometrial cancer. Research concerning possible therapeutic implications has been promising, although there is still a significant distance to be covered between research observations and clinical results. Extensive preclinical and translational research is still required to improve the efficacy and minimize unwanted effects of miRNAs-based therapy.
Non-Coding RNA as a Biomarker in Lung Cancer.
Suri C, Swarnkar S, Bhaskar L, Verma H Noncoding RNA. 2024; 10(5).
PMID: 39452836 PMC: 11514784. DOI: 10.3390/ncrna10050050.
Diagnostic Value and Molecular Function of MicroRNAs in Endometrial Diseases: A Systematic Review.
Kluz N, Kowalczyk E, Wasilewska M, Gil-Kulik P Cancers (Basel). 2024; 16(13).
PMID: 39001478 PMC: 11240806. DOI: 10.3390/cancers16132416.
Calli A, Kurt K, Narli G, Kocabey D, Yilmaz A, Ocal I Mol Biol Rep. 2024; 51(1):756.
PMID: 38874783 DOI: 10.1007/s11033-024-09663-7.
Wlodarczyk M, Ciebiera M, Nowicka G, Lozinski T, Ali M, Al-Hendy A Nutrients. 2024; 16(4).
PMID: 38398883 PMC: 10893337. DOI: 10.3390/nu16040559.
MicroRNAs as Predictors of Future Uterine Malignancy in Endometrial Hyperplasia without Atypia.
Lin C, Wu R, Yang L, Jung S, Ueng S, Tang Y J Pers Med. 2022; 12(2).
PMID: 35207799 PMC: 8879120. DOI: 10.3390/jpm12020311.